|
name  click to compare prices |
» Shop local, ethical and at the best price on Ethishop  |
|
|
|
Business & market
Subsidiaries
shareholder | country | % | source |
|
country | address & contact : production type incentive source |
China | Pekin : Production, Centre de R&D Les Echos |
|
year name | photo position; compensation source |
|
year | employees <> | social impact : country source |
|
year | employees <> | social impact : country source |
|
year | financial misdemeanor | sales | income | | buyback | source |
2008 |
| 4,61 | 0,42 | |   | billion US$ | |
2007 |
| 3,81 | 0,48 | |   | billion US$ | |
2006 |
| 3,19 | -0,02 | |   | billion US$ | |
2003 |
| 1,71 | -0,07 | |   | billion US$ | |
2003 |
Genzyme's abuse of its dominant market position has prevented viable competition and choice. |
| | | |   | | The Guardian |
2002 |
| 1,33 | -0,01 | |   | billion US$ | |
2001 |
| 1,22 | -0,11 | |   | billion US$ | |
2000 |
| 0,9 | -0,06 | |   | billion US$ | |
1998 |
| 0,69 | 0,06 | |   | billion US$ | |
|
year | financial misdemeanor | sales | income | assets | buyback | source |
|
year | purpose : intermediary/lobby : institution source |
2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington Post |
1999 | Market admission for genetically modified organisms : EuropaBio : : European Commission translate | Corporate Europe Observatory |
|
year | purpose : intermediary/lobby : institution source |
|
|
|